Published in Mol Pharmacol on January 24, 2008
Ano1, a Ca2+-activated Cl- channel, coordinates contractility in mouse intestine by Ca2+ transient coordination between interstitial cells of Cajal. J Physiol (2014) 1.02
Activation of Slo2.1 channels by niflumic acid. J Gen Physiol (2010) 0.94
Structural refinement of the hERG1 pore and voltage-sensing domains with ROSETTA-membrane and molecular dynamics simulations. Proteins (2010) 0.92
Structure-activity relationship of fenamates as Slo2.1 channel activators. Mol Pharmacol (2012) 0.88
Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels. Br J Pharmacol (2010) 0.86
Functional properties of human neuronal Kv11 channels. Pflugers Arch (2009) 0.82
Effects of the small molecule HERG activator NS1643 on Kv11.3 channels. PLoS One (2012) 0.80
Structure driven design of novel human ether-a-go-go-related-gene channel (hERG1) activators. PLoS One (2014) 0.78
In silico determination of the effect of multi-target drugs on calcium dynamics signaling network underlying sea urchin spermatozoa motility. PLoS One (2014) 0.75
A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell (1995) 11.62
HERG, a human inward rectifier in the voltage-gated potassium channel family. Science (1995) 7.26
The inward rectification mechanism of the HERG cardiac potassium channel. Nature (1996) 6.29
Fast inactivation causes rectification of the IKr channel. J Gen Physiol (1996) 3.88
Electrophysiological recording from Xenopus oocytes. Methods Enzymol (1992) 3.64
Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes. Mol Pharmacol (1990) 2.31
Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel. Mol Pharmacol (2004) 2.15
Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties. Mol Pharmacol (2004) 1.86
Potentiation of large conductance KCa channels by niflumic, flufenamic, and mefenamic acids. Biophys J (1994) 1.69
A novel role for HERG K+ channels: spike-frequency adaptation. J Physiol (1997) 1.56
Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity. Mol Pharmacol (2005) 1.47
Identification of two nervous system-specific members of the erg potassium channel gene family. J Neurosci (1997) 1.46
Mechanism of action of a novel human ether-a-go-go-related gene channel activator. Mol Pharmacol (2005) 1.43
Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Mol Pharmacol (2005) 1.37
Role of the S3-S4 linker in Shaker potassium channel activation. J Gen Physiol (1997) 1.31
Effects of premature stimulation on HERG K(+) channels. J Physiol (2001) 1.28
Glucose- and arginine-induced insulin secretion by human pancreatic beta-cells: the role of HERG K(+) channels in firing and release. FASEB J (2000) 1.28
Functions of erg K+ channels in excitable cells. J Cell Mol Med (2004) 1.15
Functional roles of an ERG current isolated in cerebellar Purkinje neurons. J Neurophysiol (2003) 1.14
Unexpected and differential effects of Cl- channel blockers on the Kv4.3 and Kv4.2 K+ channels. Implications for the study of the I(to2) current. Circ Res (1997) 1.10
Positive regulation by chloride channel blockers of IsK channels expressed in Xenopus oocytes. Mol Pharmacol (1994) 1.07
Activation and inhibition of kidney CLC-K chloride channels by fenamates. Mol Pharmacol (2005) 1.05
Direct block of the cystic fibrosis transmembrane conductance regulator Cl(-) channel by niflumic acid. Mol Membr Biol (2003) 0.97
Inhibition of hKv2.1, a major human neuronal voltage-gated K+ channel, by meclofenamic acid. Eur J Pharmacol (1999) 0.93
Fenamate-induced enhancement of heterologously expressed HERG currents in Xenopus oocytes. Eur J Pharmacol (2002) 0.92
ERG K+ channel blockade enhances firing and epinephrine secretion in rat chromaffin cells: the missing link to LQT2-related sudden death? FASEB J (2002) 0.92
Activation of ERG2 potassium channels by the diphenylurea NS1643. Neuropharmacology (2007) 0.84
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell (2004) 7.45
Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation (2007) 4.37
Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A (2005) 4.14
International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev (2005) 3.50
Interactions between S4-S5 linker and S6 transmembrane domain modulate gating of HERG K+ channels. J Biol Chem (2002) 2.34
Compound mutations: a common cause of severe long-QT syndrome. Circulation (2004) 2.29
De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res (2005) 2.27
The acid-sensitive potassium channel TASK-1 in rat cardiac muscle. Cardiovasc Res (2007) 2.00
KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain (2003) 1.92
Gating currents associated with intramembrane charge displacement in HERG potassium channels. Proc Natl Acad Sci U S A (2003) 1.82
Voltage-dependent gating of hyperpolarization-activated, cyclic nucleotide-gated pacemaker channels: molecular coupling between the S4-S5 and C-linkers. J Biol Chem (2004) 1.60
Physicochemical features of the HERG channel drug binding site. J Biol Chem (2003) 1.54
Regulation of endocytic recycling of KCNQ1/KCNE1 potassium channels. Circ Res (2007) 1.52
Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels. Proc Natl Acad Sci U S A (2002) 1.51
Molecular determinants of HERG channel block. Mol Pharmacol (2006) 1.49
Novel features of the rabbit transverse tubular system revealed by quantitative analysis of three-dimensional reconstructions from confocal images. Biophys J (2008) 1.47
Mechanism of action of a novel human ether-a-go-go-related gene channel activator. Mol Pharmacol (2005) 1.43
Heterogeneous three-dimensional anatomical and electrophysiological model of human atria. Philos Trans A Math Phys Eng Sci (2006) 1.39
Have workforce development confederations succeeded? Hosp Med (2004) 1.39
Verification of cardiac tissue electrophysiology simulators using an N-version benchmark. Philos Trans A Math Phys Eng Sci (2011) 1.37
Molecular determinants of voltage-dependent human ether-a-go-go related gene (HERG) K+ channel block. J Biol Chem (2002) 1.33
Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator. Proc Natl Acad Sci U S A (2007) 1.32
Molecular basis for Kv1.5 channel block: conservation of drug binding sites among voltage-gated K+ channels. J Biol Chem (2003) 1.30
The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel. Proc Natl Acad Sci U S A (2008) 1.30
Cardiac cell modelling: observations from the heart of the cardiac physiome project. Prog Biophys Mol Biol (2010) 1.29
Structural determinants of HERG channel block by clofilium and ibutilide. Mol Pharmacol (2004) 1.29
Regional specificity of human ether-a'-go-go-related gene channel activation and inactivation gating. J Biol Chem (2004) 1.26
Mechanisms by which atrial fibrillation-associated mutations in the S1 domain of KCNQ1 slow deactivation of IKs channels. J Physiol (2008) 1.22
Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain. Mol Pharmacol (2003) 1.20
Binding site of a novel Kv1.5 blocker: a "foot in the door" against atrial fibrillation. Mol Pharmacol (2006) 1.19
Pharmacological activation of normal and arrhythmia-associated mutant KCNQ1 potassium channels. Circ Res (2003) 1.19
Tight coupling of rubidium conductance and inactivation in human KCNQ1 potassium channels. J Physiol (2003) 1.15
Molecular determinants of KCNQ1 channel block by a benzodiazepine. Mol Pharmacol (2003) 1.14
Differential roles of S6 domain hinges in the gating of KCNQ potassium channels. Biophys J (2005) 1.13
PD-118057 contacts the pore helix of hERG1 channels to attenuate inactivation and enhance K+ conductance. Proc Natl Acad Sci U S A (2009) 1.12
Novel KChIP2 isoforms increase functional diversity of transient outward potassium currents. J Physiol (2004) 1.05
Mutation of colocalized residues of the pore helix and transmembrane segments S5 and S6 disrupt deactivation and modify inactivation of KCNQ1 K+ channels. J Physiol (2005) 1.05
Molecular determinants of hERG channel block by terfenadine and cisapride. J Pharmacol Sci (2008) 1.05
Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels. Mol Pharmacol (2005) 1.03
Modification of hERG1 channel gating by Cd2+. J Gen Physiol (2010) 1.03
Molecular determinants for activation of human ether-à-go-go-related gene 1 potassium channels by 3-nitro-n-(4-phenoxyphenyl) benzamide. Mol Pharmacol (2011) 1.02
Structural determinants of Kvbeta1.3-induced channel inactivation: a hairpin modulated by PIP2. EMBO J (2008) 1.02
Side pockets provide the basis for a new mechanism of Kv channel-specific inhibition. Nat Chem Biol (2013) 0.99
Stoichiometry of altered hERG1 channel gating by small molecule activators. J Gen Physiol (2014) 0.99
Structural determinants for high-affinity block of hERG potassium channels. Novartis Found Symp (2005) 0.97
Relaxation gating of the acetylcholine-activated inward rectifier K+ current is mediated by intrinsic voltage sensitivity of the muscarinic receptor. J Physiol (2011) 0.97
Impaired interaction between the slide helix and the C-terminus of Kir2.1: a novel mechanism of Andersen syndrome. Cardiovasc Res (2007) 0.96
Structural determinants and biophysical properties of HERG and KCNQ1 channel gating. J Mol Cell Cardiol (2003) 0.95
Long QT syndrome-associated mutations in KCNQ1 and KCNE1 subunits disrupt normal endosomal recycling of IKs channels. Circ Res (2008) 0.95
Activation of Slo2.1 channels by niflumic acid. J Gen Physiol (2010) 0.94
Molecular mapping of a site for Cd2+-induced modification of human ether-à-go-go-related gene (hERG) channel activation. J Physiol (2005) 0.93
Knock-out of the potassium channel TASK-1 leads to a prolonged QT interval and a disturbed QRS complex. Cell Physiol Biochem (2011) 0.93
Towards modeling of cardiac micro-structure with catheter-based confocal microscopy: a novel approach for dye delivery and tissue characterization. IEEE Trans Med Imaging (2009) 0.92
Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation. NMR Biomed (2014) 0.91
Block of wild-type and inactivation-deficient human ether-a-go-go-related gene K+ channels by halofantrine. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.90
Molecular mapping of the binding site for a blocker of hyperpolarization-activated, cyclic nucleotide-modulated pacemaker channels. J Pharmacol Exp Ther (2007) 0.90
Cooperative interactions between R531 and acidic residues in the voltage sensing module of hERG1 channels. Cell Physiol Biochem (2008) 0.90
TASK-1 channels may modulate action potential duration of human atrial cardiomyocytes. Cell Physiol Biochem (2011) 0.90
Modeling of IK1 mutations in human left ventricular myocytes and tissue. Am J Physiol Heart Circ Physiol (2006) 0.89
Strain transfer in ventricular cardiomyocytes to their transverse tubular system revealed by scanning confocal microscopy. Biophys J (2011) 0.89
Stochastic Markovian modeling of electrophysiology of ion channels: reconstruction of standard deviations in macroscopic currents. J Theor Biol (2006) 0.89
A novel Markov model projecting costs and outcomes of providing antiretroviral therapy to public patients in private practices versus public clinics in South Africa. PLoS One (2013) 0.88
Structure-activity relationship of fenamates as Slo2.1 channel activators. Mol Pharmacol (2012) 0.88
Marine algal toxin azaspiracid is an open-state blocker of hERG potassium channels. Chem Res Toxicol (2012) 0.88
Tuning of EAG K(+) channel inactivation: molecular determinants of amplification by mutations and a small molecule. J Gen Physiol (2012) 0.87
Three-dimensional modeling and quantitative analysis of gap junction distributions in cardiac tissue. Ann Biomed Eng (2011) 0.87
Molecular determinants of Kv1.5 channel block by diphenyl phosphine oxide-1. J Mol Cell Cardiol (2010) 0.87
Reduced transient outward K+ current and cardiac hypertrophy: causal relationship or epiphenomenon? Circ Res (2002) 0.86
Electrical stimulation directs engineered cardiac tissue to an age-matched native phenotype. J Tissue Eng (2012) 0.86
Niflumic acid alters gating of HCN2 pacemaker channels by interaction with the outer region of S4 voltage sensing domains. Mol Pharmacol (2009) 0.86
Structural basis of ion permeation gating in Slo2.1 K+ channels. J Gen Physiol (2013) 0.85
Modeling effects of L-type ca(2+) current and na(+)-ca(2+) exchanger on ca(2+) trigger flux in rabbit myocytes with realistic T-tubule geometries. Front Physiol (2012) 0.85
Molecular determinants of human ether-à-go-go-related gene 1 (hERG1) K+ channel activation by NS1643. Mol Pharmacol (2010) 0.85
Mechanical modulation of the transverse tubular system of ventricular cardiomyocytes. Prog Biophys Mol Biol (2012) 0.85
Quantitative analysis of cardiac tissue including fibroblasts using three-dimensional confocal microscopy and image reconstruction: towards a basis for electrophysiological modeling. IEEE Trans Med Imaging (2013) 0.84
A family approach to severe mental illness in post-war Kosovo. Psychiatry (2005) 0.83
Molecular basis for a high-potency open-channel block of Kv1.5 channel by the endocannabinoid anandamide. Mol Pharmacol (2010) 0.83
A single amino acid difference between ether-a-go-go- related gene channel subtypes determines differential sensitivity to a small molecule activator. Mol Pharmacol (2007) 0.83
A highly conserved alanine in the S6 domain of the hERG1 K+ channel is required for normal gating. Cell Physiol Biochem (2008) 0.83
The ecology of attachment in the family. Fam Process (2003) 0.82
Identification of nodal tissue in the living heart using rapid scanning fiber-optics confocal microscopy and extracellular fluorophores. Circ Cardiovasc Imaging (2013) 0.82
Sample Core Competencies in Child and Adolescent Psychiatry Training: A Starting Point. Acad Psychiatry (2001) 0.82
Chloroquine blocks a mutant Kir2.1 channel responsible for short QT syndrome and normalizes repolarization properties in silico. Cell Physiol Biochem (2009) 0.81
3-OST-7 regulates BMP-dependent cardiac contraction. PLoS Biol (2013) 0.81
Voltage sensing and activation gating of HCN pacemaker channels. Trends Cardiovasc Med (2002) 0.80
Voltage sensor movement in the hERG K+ channel. Novartis Found Symp (2005) 0.80
Modelling of short QT syndrome in a heterogeneous model of the human ventricular wall. Europace (2005) 0.80
Progress report on the development of child abuse prevention, identification, and treatment systems in Eastern Europe. Child Abuse Negl (2004) 0.79
ICA-105574 interacts with a common binding site to elicit opposite effects on inactivation gating of EAG and ERG potassium channels. Mol Pharmacol (2013) 0.79
Modeling of cardiac ischemia in human myocytes and tissue including spatiotemporal electrophysiological variations. Biomed Tech (Berl) (2009) 0.78
Voltage sensitivity of M2 muscarinic receptors underlies the delayed rectifier-like activation of ACh-gated K(+) current by choline in feline atrial myocytes. J Physiol (2013) 0.78